Physician profile
Javier E Lopez
NPI 1508800442
$38,066.20
in general payments reported to CMS, 2019-2025
78 companies · $6,521 in 2025
The $6,521 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,179 · 2020: $2,804 · 2021: $5,694 · 2022: $5,877 · 2023: $6,752 · 2024: $7,240 · 2025: $6,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Education: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,897.74 |
| Education | $615.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,159.68 | 2019-2025 | |
| Ucb, INC. | $3,952.85 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Emd Serono, INC. | $1,949.65 | 2019-2025 | Mavenclad, Mavenclad |
| Teva Pharmaceuticals USA, INC. | $1,836.13 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $1,781.07 | 2019-2025 | |
| Biogen, INC. | $1,716.44 | 2019-2025 | Tysabri, Vumerity, Plegridy |
| Lilly USA, LLC | $1,384.99 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Mallinckrodt Hospital Products INC. | $1,236.57 | 2020-2025 | Acthar |
| Amgen INC. | $1,123.87 | 2019-2025 | Uplizna |
| Neurocrine Biosciences, INC. | $1,100.52 | 2022-2025 | Ingrezza, Ongentys |
| Eisai INC. | $1,064.82 | 2021-2025 | |
| Sk Life Science, INC. | $999.88 | 2020-2025 | Xcopri |
| Pfizer INC. | $919.41 | 2019-2025 | |
| Allergan, INC. | $888.52 | 2019-2022 | |
| Lundbeck LLC | $856.90 | 2020-2025 | Rexulti, Vyepti |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $852.55 | 2019-2025 | Hizentra |
| Argenx US, INC. | $746.89 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amneal Pharmaceuticals LLC | $670.14 | 2019-2025 | Rytary, Crexont, Ongentys |
| Neurelis, INC. | $633.32 | 2021-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $566.42 | 2019-2025 | Ultomiris, Soliris |
| Kyowa Kirin, INC. | $542.84 | 2019-2024 | Nourianz |
| Acadia Pharmaceuticals INC | $504.73 | 2019-2025 | Nuplazid |
| Adamas Pharmaceuticals, INC. | $487.53 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $453.13 | 2023-2025 | Rexulti, Nuedexta |
| Biohaven Pharmaceuticals, INC. | $448.75 | 2020-2021 | |
| Tg Therapeutics, INC. | $423.95 | 2023-2025 | |
| Upsher-Smith Laboratories LLC | $415.09 | 2019-2023 | |
| Acorda Therapeutics, INC | $386.80 | 2019-2024 | Inbrija, Ampyra |
| Scilex Pharmaceuticals INC. | $347.02 | 2019-2024 | Ztlido |
| Tanabe Pharma America, INC. | $341.38 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $339.62 | 2020-2025 | Hyqvia, Gammagard |
| Celgene Corporation | $303.45 | 2021-2023 | Zeposia |
| Genzyme Corporation | $299.85 | 2019-2025 | |
| Almatica Pharma LLC | $295.23 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $258.16 | 2022-2023 | |
| Mdd US Operations, LLC | $238.82 | 2019-2025 | Apokyn |
| Akcea Therapeutics, INC. | $238.03 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $231.39 | 2021-2025 | Wainua, Evusheld |
| Sunovion Pharmaceuticals INC. | $222.67 | 2019-2022 | |
| Janssen Biotech, INC. | $197.55 | 2025 | |
| Avion Pharmaceuticals | $195.57 | 2021-2023 | Dhivy |
| Aprecia Pharmaceuticals, LLC | $194.09 | 2022-2023 | Spritam |
| E.R. Squibb & Sons, L.L.C. | $165.33 | 2020-2021 | |
| Livanova USA, INC. | $143.25 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Banner Life Sciences, LLC | $124.71 | 2022-2024 | |
| Genentech USA, INC. | $121.25 | 2022-2025 | Ocrevus, Ocrevus Zunovo |
| Avanir Pharmaceuticals, INC. | $120.84 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $120.46 | 2019-2021 | |
| Chiesi USA, INC. | $116.85 | 2021 | |
| Boston Scientific Corporation | $109.08 | 2019-2025 | Watchman Flx |
| Abbott Laboratories | $108.48 | 2022-2025 | Infinity, Eterna |
| Cycle Pharmaceuticals INC | $104.82 | 2025 | Tascenso Odt, Bafiertam |
| Alfasigma USA, INC. | $104.42 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $93.33 | 2022 | |
| Merz Pharmaceuticals, LLC | $89.89 | 2024-2025 | Xeomin, Inbrija, Ampyra |
| Axsome Therapeutics, INC. | $80.08 | 2025 | Symbravo |
| Ani Pharmaceuticals, INC. | $67.62 | 2025 | Purified Cortrophin Gel |
| Microtransponder, INC. | $62.03 | 2025 | |
| Janssen Pharmaceuticals, INC | $40.61 | 2021 | |
| Aquestive Therapeutics, INC. | $38.40 | 2019 | |
| Insightec,INC | $34.96 | 2023-2024 | Exablate |
| Corium, LLC | $34.84 | 2023 | Adlarity |
| Catalyst Pharmaceuticals, INC. | $34.71 | 2021 | |
| Currax Pharmaceuticals LLC | $30.90 | 2020 | |
| Grifols USA, LLC | $30.03 | 2019 | |
| Nevro Corp. | $29.48 | 2022 | |
| Life Molecular Imaging Ltd | $27.52 | 2024 | Neuraceq |
| Alnylam Pharmaceuticals INC. | $24.91 | 2023 | Onpattro |
| Octapharma USA, INC. | $24.76 | 2025 | Panzyga |
| Vertical Pharmaceuticals, LLC | $23.42 | 2019 | |
| Xeris Pharmaceuticals, INC. | $23.40 | 2025 | Keveyis |
| Sobi, INC | $21.86 | 2021 | |
| Horizon Therapeutics Plc | $21.10 | 2022 | |
| Arbor Pharmaceuticals, INC. | $21.06 | 2019 | |
| Philips North America LLC | $20.43 | 2019 | |
| Cala Health, INC. | $17.15 | 2022 | |
| Hyperfine Operations, INC. | $16.93 | 2025 | Swoop |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.